“i4i FAST (Funding At the Speed of Translation) Pilot 2 is a new funding scheme, designed to address an evidence gap. Research themes can be in any area of existing or emerging clinical need.“
i4i FAST (Funding At the Speed of Translation) Pilot 2 is a new funding scheme aimed at innovators in need of a small amount of funding to answer a specific question or to fund a single piece of activity.
These awards are designed to address an evidence gap across different developmental levels, from innovations with initial proof-of-concept (starting from TRL stage 3) to mature innovations. Research themes can be in any area of existing or emerging clinical need.
- SMEs with a staff headcount no greater than 250 and annual turnover no greater than €50 million (including start-up or spin-out companies). Companies must be registered on Companies House prior to applying to i4i FAST to be eligible for funding.
- NHS organisations (including NHS Trusts and NHS Foundation Trusts), and equivalent UK authorities.
- Higher education institutions (including universities and research institutes).
- Not-for-profit organisations (including charities and Community Interest Companies).
The Invention for Innovation (i4i) programme is a translational funding scheme which advances healthcare technologies and interventions for increased patient benefit in areas of existing or emerging healthcare need. It supports the research and development of medical devices, in vitro diagnostics and high-impact patient-focused digital health technologies (including AI) for ultimate NHS use, to a point where they are de-risked for follow-on investment.